• 1. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 2. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 3. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 4. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 5. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459

• Solvents and Organic Chemicals Organic Compounds Organic 1,3-dipolar compounds Allyl-type 1,3-dipolar organic compounds C-nitro compounds
• Solvents and Organic Chemicals Organic Compounds Organic 1,3-dipolar compounds Allyl-type 1,3-dipolar organic compounds Organic nitro compounds C-nitro compounds

Introduction to 1-Benzyl-5-methyl-3-nitro-1H-pyrazole (CAS No. 898053-54-8)

1-Benzyl-5-methyl-3-nitro-1H-pyrazole (CAS No. 898053-54-8) is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research due to its unique structural properties and potential biological activities. This compound belongs to the pyrazole class, which is well-documented for its wide-ranging applications in drug discovery and development. The presence of a benzyl group, a methyl group, and a nitro group in its molecular structure contributes to its diverse chemical reactivity and functional versatility, making it a valuable scaffold for further chemical modifications and biological evaluations.

The nitro group in 1-Benzyl-5-methyl-3-nitro-1H-pyrazole is particularly noteworthy, as nitro-substituted pyrazoles have been extensively studied for their pharmacological effects. Nitro compounds often exhibit interesting electronic properties, which can influence their interactions with biological targets. This feature has led to their exploration in various therapeutic areas, including anti-inflammatory, antimicrobial, and anticancer applications. The methyl group at the 5-position of the pyrazole ring further enhances the compound's complexity, potentially affecting its metabolic stability and bioavailability. The benzyl group, located at the 1-position, introduces an aromatic ring that can participate in π-stacking interactions and hydrogen bonding, which are crucial for molecular recognition processes.

In recent years, there has been a growing interest in developing novel heterocyclic compounds for medicinal applications. Pyrazoles, in particular, have been recognized as privileged structures due to their inherent biological activity and synthetic accessibility. The 1-Benzyl-5-methyl-3-nitro-1H-pyrazole molecule represents a promising candidate for further investigation due to its structural features that are conducive to drug-like properties. Studies have shown that nitro-substituted pyrazoles can exhibit potent activity against various disease targets by modulating key biological pathways.

One of the most compelling aspects of 1-Benzyl-5-methyl-3-nitro-1H-pyrazole is its potential as a lead compound for drug development. Researchers have been exploring its derivatives to optimize pharmacokinetic profiles and enhance therapeutic efficacy. The nitro group can be reduced to an amine, opening up possibilities for further functionalization. This chemical versatility allows for the design of molecules with tailored properties, making 1-Benzyl-5-methyl-3-nitro-1H-pyrazole a versatile starting point for medicinal chemists.

The benzyl group in this compound can also be modified through various chemical reactions, such as hydrolysis or coupling reactions, to introduce additional functional groups or linkages. This flexibility is particularly valuable in the development of prodrugs or conjugates that require specific targeting or release mechanisms. The methyl group, while relatively inert compared to other substituents, contributes to the overall steric environment of the molecule, which can influence binding affinity and selectivity.

Recent advancements in computational chemistry have enabled more efficient screening of potential drug candidates like 1-Benzyl-5-methyl-3-nitro-1H-pyrazole. Molecular docking studies have been employed to predict interactions with biological targets such as enzymes and receptors. These virtual screening approaches have identified several promising derivatives of this compound that show enhanced activity against specific disease markers. For instance, modifications at the nitro group have led to compounds with improved anti-inflammatory properties by inhibiting key inflammatory enzymes.

The synthesis of 1-Benzyl-5-methyl-3-nitro-1H-pyrazole involves multi-step organic transformations that highlight the compound's synthetic accessibility. The process typically begins with the preparation of a pyrazole core, followed by nitration and benzylation steps. This synthetic route underscores the compound's feasibility for large-scale production if needed for preclinical or clinical studies.

Beyond its pharmaceutical potential, 1-Benzyl-5-methyl-3-nitro-1H-pyrazole has also been explored in material science applications due to its aromatic structure and electronic properties. Researchers have investigated its use in organic electronics and as a precursor for more complex materials with specialized functions.

In conclusion, 1-Benzyl-5-methyl-3-nitro-H-pyrazole (CAS No. 89805354) is a multifaceted compound with significant promise in both pharmaceuticals and materials science. Its unique structural features make it an attractive candidate for further research and development aimed at discovering new therapeutics and advanced materials.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)